Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain

Abstract Background Analgesic treatment is the primary method for managing acute postoperative pain. Opioid analgesics are the main class of drugs used to treat moderate to severe pain, whether it is acute or chronic. These opioids differ in various ways, including their pharmacochemical properties,...

Full description

Saved in:
Bibliographic Details
Main Authors: Mateusz Szczupak, Jacek Kobak, Maria Cimoszko-Zauliczna, Sabina Krupa‑Nurcek, Anna Ingielewicz, Jolanta Wierzchowska
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Anesthesiology
Subjects:
Online Access:https://doi.org/10.1186/s12871-025-03084-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850143436900925440
author Mateusz Szczupak
Jacek Kobak
Maria Cimoszko-Zauliczna
Sabina Krupa‑Nurcek
Anna Ingielewicz
Jolanta Wierzchowska
author_facet Mateusz Szczupak
Jacek Kobak
Maria Cimoszko-Zauliczna
Sabina Krupa‑Nurcek
Anna Ingielewicz
Jolanta Wierzchowska
author_sort Mateusz Szczupak
collection DOAJ
description Abstract Background Analgesic treatment is the primary method for managing acute postoperative pain. Opioid analgesics are the main class of drugs used to treat moderate to severe pain, whether it is acute or chronic. These opioids differ in various ways, including their pharmacochemical properties, distribution and absorption rates, metabolism, and elimination pathways for the drug and its metabolites. These differences result in varying degrees of analgesic efficacy, which, in clinical practice, allows for the selection of the most effective drug that maximizes pain relief while ensuring safety. Buprenorphine is a semi-synthetic opioid with properties that are not yet fully understood. It has a wide range of applications in treating both acute and chronic pain, including non-cancer and cancer-related pain. One of the most significant clinical advantages of buprenorphine is its safety profile, which includes a ceiling effect on respiratory depression, no immunosuppressive effects, inhibition of hyperalgesia, no cumulative effects in patients with renal failure, and a low risk of constipation following its use. Aim This study aims to analyze current reports on the use of intravenous buprenorphine as a first-line opioid analgesic for postoperative pain relief. The paper discusses the pharmacochemical properties of the drug and the mechanisms behind postoperative pain. Additionally, it presents the experiences of the pain management team at Copernicus Hospital in Gdansk regarding administering intravenous buprenorphine. Material and methods The current literature on buprenorphine for treating moderate to severe acute pain has been reviewed, focusing on its effectiveness in managing postoperative pain following surgical procedures. Additionally, the experience of the Copernicus Hospital pain team with buprenorphine is summarized in a brief discussion. Conclusion After reviewing current literature and recommendations, along with the experiences of the pain management team at Copernicus Hospital in Gdańsk, it can be concluded that buprenorphine is an analgesic that demonstrates a high level of efficacy and safety. When used in combination with non-opioid analgesics, buprenorphine achieves a synergistic effect, resulting in effective pain relief. This approach facilitates early patient rehabilitation and enables a swift return to normal activities, even following extensive surgical procedures.
format Article
id doaj-art-0b57843d5dde4b7084192e91dc97cef3
institution OA Journals
issn 1471-2253
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series BMC Anesthesiology
spelling doaj-art-0b57843d5dde4b7084192e91dc97cef32025-08-20T02:28:42ZengBMCBMC Anesthesiology1471-22532025-04-0125111410.1186/s12871-025-03084-0Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative painMateusz Szczupak0Jacek Kobak1Maria Cimoszko-Zauliczna2Sabina Krupa‑Nurcek3Anna Ingielewicz4Jolanta Wierzchowska5Department of Anesthesiology and Intensive Care, Copernicus HospitalDepartment of Otolaryngology, Faculty of Medicine, Medical University of GdanskDepartment of Anesthesiology and Intensive Care, Copernicus HospitalDepartment of Surgery, Institute of Medical Sciences, Medical College of Rzeszów UniversityDepartment of Emergency Medicine, Faculty of Health Science, Medical University of GdanskDepartment of Anesthesiology and Intensive Care, Copernicus HospitalAbstract Background Analgesic treatment is the primary method for managing acute postoperative pain. Opioid analgesics are the main class of drugs used to treat moderate to severe pain, whether it is acute or chronic. These opioids differ in various ways, including their pharmacochemical properties, distribution and absorption rates, metabolism, and elimination pathways for the drug and its metabolites. These differences result in varying degrees of analgesic efficacy, which, in clinical practice, allows for the selection of the most effective drug that maximizes pain relief while ensuring safety. Buprenorphine is a semi-synthetic opioid with properties that are not yet fully understood. It has a wide range of applications in treating both acute and chronic pain, including non-cancer and cancer-related pain. One of the most significant clinical advantages of buprenorphine is its safety profile, which includes a ceiling effect on respiratory depression, no immunosuppressive effects, inhibition of hyperalgesia, no cumulative effects in patients with renal failure, and a low risk of constipation following its use. Aim This study aims to analyze current reports on the use of intravenous buprenorphine as a first-line opioid analgesic for postoperative pain relief. The paper discusses the pharmacochemical properties of the drug and the mechanisms behind postoperative pain. Additionally, it presents the experiences of the pain management team at Copernicus Hospital in Gdansk regarding administering intravenous buprenorphine. Material and methods The current literature on buprenorphine for treating moderate to severe acute pain has been reviewed, focusing on its effectiveness in managing postoperative pain following surgical procedures. Additionally, the experience of the Copernicus Hospital pain team with buprenorphine is summarized in a brief discussion. Conclusion After reviewing current literature and recommendations, along with the experiences of the pain management team at Copernicus Hospital in Gdańsk, it can be concluded that buprenorphine is an analgesic that demonstrates a high level of efficacy and safety. When used in combination with non-opioid analgesics, buprenorphine achieves a synergistic effect, resulting in effective pain relief. This approach facilitates early patient rehabilitation and enables a swift return to normal activities, even following extensive surgical procedures.https://doi.org/10.1186/s12871-025-03084-0BuprenorphineAcute postoperative painOpioid analgesiaIntravenous buprenorphinePain
spellingShingle Mateusz Szczupak
Jacek Kobak
Maria Cimoszko-Zauliczna
Sabina Krupa‑Nurcek
Anna Ingielewicz
Jolanta Wierzchowska
Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
BMC Anesthesiology
Buprenorphine
Acute postoperative pain
Opioid analgesia
Intravenous buprenorphine
Pain
title Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
title_full Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
title_fullStr Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
title_full_unstemmed Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
title_short Strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
title_sort strategy for effective analgesia with intravenous buprenorphine in patients with acute postoperative pain
topic Buprenorphine
Acute postoperative pain
Opioid analgesia
Intravenous buprenorphine
Pain
url https://doi.org/10.1186/s12871-025-03084-0
work_keys_str_mv AT mateuszszczupak strategyforeffectiveanalgesiawithintravenousbuprenorphineinpatientswithacutepostoperativepain
AT jacekkobak strategyforeffectiveanalgesiawithintravenousbuprenorphineinpatientswithacutepostoperativepain
AT mariacimoszkozauliczna strategyforeffectiveanalgesiawithintravenousbuprenorphineinpatientswithacutepostoperativepain
AT sabinakrupanurcek strategyforeffectiveanalgesiawithintravenousbuprenorphineinpatientswithacutepostoperativepain
AT annaingielewicz strategyforeffectiveanalgesiawithintravenousbuprenorphineinpatientswithacutepostoperativepain
AT jolantawierzchowska strategyforeffectiveanalgesiawithintravenousbuprenorphineinpatientswithacutepostoperativepain